Yasir Hassan

Board Member OVIBIO

Conference Day One

3:40 PM OPINION PIECE: THE BIOSECURE ACT & NAVIGATING A NEW LANDSCAPE FOR PHARMA CONTRACT MANUFACTURING

The BIOSECURE Act has ushered in a new era for the pharma contract manufacturing industry. This session will explore the key implications of the Act, focusing on its impact on European pharma and CMOs. We will delve into the specific provisions of the Act, assess its potential influence on global supply chains.


Check out the incredible speaker line-up to see who will be joining Yasir.

Download The Latest Agenda